Cargando…
Correction to: Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
Autores principales: | Lv, Lei, Zhao, Yujia, Wei, Qinqin, Zhao, Ye, Yi, Qiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532554/ https://www.ncbi.nlm.nih.gov/pubmed/33024417 http://dx.doi.org/10.1186/s12935-020-01575-3 |
Ejemplares similares
-
Downexpression of HSD17B6 correlates with clinical prognosis and tumor immune infiltrates in hepatocellular carcinoma
por: Lv, Lei, et al.
Publicado: (2020) -
HSD17B6 downregulation predicts poor prognosis and drives tumor progression via activating Akt signaling pathway in lung adenocarcinoma
por: Tian, Tian, et al.
Publicado: (2021) -
Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma
por: Lv, Lei, et al.
Publicado: (2021) -
Correction: CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Publicado: (2022) -
Correction to: Lost in promiscuity? An evolutionary and biochemical evaluation of HSD10 function in cardiolipin metabolism
por: Wohlfarter, Yvonne, et al.
Publicado: (2023)